{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T08:40:35Z","timestamp":1768120835817,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.cyto.2016.04.009","type":"journal-article","created":{"date-parts":[[2016,5,3]],"date-time":"2016-05-03T17:20:09Z","timestamp":1462296009000},"page":"171-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Levels of serum pentraxin 3, IL-6, fetuin A and insulin in patients with rheumatoid arthritis"],"prefix":"10.1016","volume":"83","author":[{"given":"\u0130brahim","family":"Tekeo\u011flu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halil","family":"Harman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinem","family":"Sa\u011f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Alt\u0131ndi\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayhan","family":"Kamanl\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5845-0851","authenticated-orcid":false,"given":"Kemal","family":"Nas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2016.04.009_b0005","first-page":"681","article-title":"Independent role of conventional cardiovascular risk factors as predictors of C-reactive protein concentrations in rheumatoid arthritis","volume":"34","author":"Dessein","year":"2007","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.cyto.2016.04.009_b0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.semarthrit.2005.03.004","article-title":"Rheumatoid arthritis: a disease associated with accelerated atherogenesis","volume":"35","author":"Gonzalez-Gay","year":"2005","journal-title":"Semin. Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.cyto.2016.04.009_b0015","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/ar3891","article-title":"Inflammation, endothelial function and atherosclerosis in rheumatoid arthritis","volume":"14","author":"Gonzalez-Juanatey","year":"2012","journal-title":"Arthritis Res. Ther."},{"issue":"Suppl. 2","key":"10.1016\/j.cyto.2016.04.009_b0020","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0264-410X(03)00199-3","article-title":"Pentraxin 3, a non-redundant soluble pattern recognition receptor involved in innate immunity","volume":"21","author":"Mantovani","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.cyto.2016.04.009_b0025","first-page":"415","article-title":"Longpentraxin 3: a marker of inflammation in untreatedpsoriatic patients","volume":"18","author":"Bevelacqua","year":"2006","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.cyto.2016.04.009_b0030","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ahj.2011.11.007","article-title":"Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study","volume":"163","author":"Dubin","year":"2012","journal-title":"Am. Heart J."},{"key":"10.1016\/j.cyto.2016.04.009_b0035","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000324916","article-title":"Uric acid and pentraxin-3 levels are independently associated with coronary artery disease risk in patients with stage 2 and 3 kidney disease","volume":"33","author":"Kanbay","year":"2011","journal-title":"Am. J. Nephrol."},{"issue":"1","key":"10.1016\/j.cyto.2016.04.009_b0040","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3109\/s10165-012-0630-0","article-title":"Serum amyloid A (SAA) induces pentraxin 3 (PTX3) production in rheumatoid synoviocytes","volume":"23","author":"Satomura","year":"2013","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.cyto.2016.04.009_b0045","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1681\/ASN.2009080820","article-title":"Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK","volume":"21","author":"Ix","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cyto.2016.04.009_b0050","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/MCA.0b013e32832fe5d5","article-title":"Fetuin-A is associated with calcified coronary artery disease","volume":"21","author":"Mori","year":"2010","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.cyto.2016.04.009_b0055","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/jid.2010.103","article-title":"Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions","volume":"130","author":"Davidovici","year":"2010","journal-title":"J. Invest. Dermatol."},{"issue":"11","key":"10.1016\/j.cyto.2016.04.009_b0060","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/eji.1830181122","article-title":"Excessive production of interleukin 6\/B cell stimulatory factor-2 in rheumatoid arthritis","volume":"18","author":"Hirano","year":"1988","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2016.04.009_b0065","first-page":"510243","article-title":"Marked independent relationship between circulating interleukin-6 concentrations and endothelial activation in rheumatoid arthritis","volume":"2013","author":"Dessein","year":"2013","journal-title":"Mediators Inflamm."},{"issue":"9","key":"10.1016\/j.cyto.2016.04.009_b0070","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1002\/art.27580","article-title":"The 2010 American College of Rheumatology\/European League Against Rheumatism classification criteria for rheumatoid arthritis: phase 2 methodological report","volume":"62","author":"Neogi","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cyto.2016.04.009_b0075","unstructured":"Physical status the use and interpretation of anthropometry, Report of a WHO Expert Committee, World Health Organ Tech Rep Ser 854, 1995, pp. 1\u2013452."},{"issue":"6","key":"10.1016\/j.cyto.2016.04.009_b0080","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1136\/ard.2007.084459","volume":"68","author":"Wells","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.cyto.2016.04.009_b0085","first-page":"1936","article-title":"Health assessment questionnaire score is the best predictor of 5-year quality of life in early rheumatoid arthritis","volume":"33","author":"Cohen","year":"2006","journal-title":"J. Rheumatol."},{"issue":"6","key":"10.1016\/j.cyto.2016.04.009_b0090","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.cyto.2016.04.009_b0095","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1253\/circj.CJ-08-0473","article-title":"Inflammatory cell infiltrates in vessels with different susceptibility to atherosclerosis in rheumatic and non-rheumatic patients","volume":"72","author":"Hollan","year":"2008","journal-title":"Circ. J."},{"issue":"8","key":"10.1016\/j.cyto.2016.04.009_b0100","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/CIRCULATIONAHA.108.806547","article-title":"Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis","volume":"120","author":"Norata","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2016.04.009_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.immunol.23.021704.115806","article-title":"Interleukin-6: from basic science to medicine \u2013 40 years in immunology","volume":"23","author":"Kishimoto","year":"2005","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2016.04.009_b0110","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/03009740600904300","article-title":"Plasma IL-6, plasma VEGF, and serum YKL-40: relationship with disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab and methotrexate","volume":"35","author":"Knudsen","year":"2006","journal-title":"Scand. J. Rheumatol."},{"issue":"7","key":"10.1016\/j.cyto.2016.04.009_b0115","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/acr.22513","article-title":"Evaluation of serum interleukin-6 level as a surrogate marker of synovial inflammation and as a factor of structural progression in early rheumatoid arthritis: results from a French national multicenter cohort","volume":"67","author":"Baillet","year":"2015","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.cyto.2016.04.009_b0120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-immunol-030409-101305","article-title":"An integrated view of humoral innate immunity: pentraxins as a paradigm","volume":"28","author":"Bottazzi","year":"2010","journal-title":"Annu. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2016.04.009_b0125","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ni.1854","article-title":"Regulation of leukocyte recruitment by the long pentraxin PTX3","volume":"11","author":"Deban","year":"2010","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2016.04.009_b0130","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.1365-2249.2000.01110.x","article-title":"Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA)","volume":"119","author":"Luchetti","year":"2000","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2016.04.009_b0135","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.carpath.2013.01.007","article-title":"Pentraxin 3, a novel cardiovascular biomarker, is expressed in aortic specimens of patients with coronary artery disease with and without rheumatoid arthritis","volume":"22","author":"Hollan","year":"2013","journal-title":"Cardiovasc. Pathol."},{"key":"10.1016\/j.cyto.2016.04.009_b0140","doi-asserted-by":"crossref","first-page":"681635","DOI":"10.1155\/2014\/681635","article-title":"Differential associations of inflammatory and endothelial biomarkers with disease activity in rheumatoid arthritis of short duration","volume":"2014","author":"Klimek","year":"2014","journal-title":"Mediators Inflamm."},{"issue":"1","key":"10.1016\/j.cyto.2016.04.009_b0145","first-page":"87","article-title":"Serum pentraxin 3 and interleukin-6 are associated with subclinical atherosclerosis in recent-onset rheumatoid arthritis","volume":"17","author":"Mabrouk","year":"2010","journal-title":"Egypt J. Immunol."},{"issue":"18","key":"10.1016\/j.cyto.2016.04.009_b0150","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.1158\/0008-5472.CAN-04-1117","article-title":"Alpha2HS-glycoprotein, an antagonist of transforming growth factor beta in vivo, inhibits intestinal tumor progression","volume":"64","author":"Swallow","year":"2004","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.cyto.2016.04.009_b0155","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.yexcr.2013.12.003","article-title":"Alpha-2 Heremans Schmid Glycoprotein (AHSG) modulates signaling pathways in head and neck squamous cell carcinoma cell line SQ20B","volume":"321","author":"Thompson","year":"2014","journal-title":"Exp. Cell Res."},{"issue":"9","key":"10.1016\/j.cyto.2016.04.009_b0160","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1097\/MEG.0b013e32835fd699","article-title":"APRI, the FIB-4 score, and Forn\u2019s index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B","volume":"25","author":"Ucar","year":"2013","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.cyto.2016.04.009_b0165","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000245042","article-title":"Coronary calcifications in end-stage renal disease patients: a new link between osteoprotegerin, diabetes and body mass index?","volume":"29","author":"Cianciolo","year":"2010","journal-title":"Blood Purif."},{"issue":"20","key":"10.1016\/j.cyto.2016.04.009_b0170","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.2169\/internalmedicine.46.6269","article-title":"Decreased levels of circulating alpha2-Heremans-Schmid glycoprotein\/Fetuin-A(AHSG) in patients with rheumatoid arthritis","volume":"46","author":"Sato","year":"2007","journal-title":"Intern. Med."},{"issue":"2","key":"10.1016\/j.cyto.2016.04.009_b0175","doi-asserted-by":"crossref","first-page":"e56246","DOI":"10.1371\/journal.pone.0056246","article-title":"Identification of novel autoantigen in the synovial fluid of rheumatoid arthritis patients using an immunoproteomics approach","volume":"8","author":"Biswas","year":"2013","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.cyto.2016.04.009_b0180","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2174\/1573399811666150602150325","article-title":"Effect of systemic inflammation on the function of insulin and glucose metabolism in rheumatoid arthritis","volume":"12","author":"Herlitz-Cifuentes","year":"2015","journal-title":"Curr. Diabetes Rev."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466616300679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466616300679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T09:58:39Z","timestamp":1536746319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466616300679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":36,"alternative-id":["S1043466616300679"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2016.04.009","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levels of serum pentraxin 3, IL-6, fetuin A and insulin in patients with rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2016.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}